Sign in
Taking peopleNo phase

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Key facts

Who runs it
Hvidovre University Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
11 people, planned
Started
3 Jan 2024
Expected to end
1 Dec 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Dietary macronutrient composition
Record updated
16 November 2026

Who can take part

Age
35 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Men or women
  • 35-75 years old
  • BMI >27 kg/m2
  • Known type 2 diabetes in stable glucose lowering therapy (for three months) or with HbA1c >48 mmol/mol if no glucose lowering therapy

Who cannot take part

  • Treatment with insulin or sulfonylurea
  • Treatment with systemic corticosteroids
  • Weight loss (>5 kg) within the last three months or previous bariatric surgery
  • Thyroid disease if not well controlled based on patient reporting and/or the most recent measurement of TSH
  • History of advanced liver fibrosis or cirrhosis
  • Food allergies (including lactose and gluten intolerance)
  • Anemia (hemoglobin <8 mmol/L for men and <7 mmol/L for women)
  • Severely dysregulated diabetes defined by HbA1c >70 mmol/mol
  • Kidney failure (eGFR <30 ml/min/1.73 m²) based on patient reporting and/or the most recent control measurement
  • Vegetarian/vegan diet or following of specific dietary plans
  • Alcohol consumptions >84/168 g/week (women/men)
  • Strenuous activity level > 120 minutes per week

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 35 and 75 years old?

This trial is currently available in Denmark.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The primary aim of this randomized cross-over intervention study is to investigate the effect of 16 days of intermittent carbohydrate restriction (alternating between two days of a conventional control diet and, two days of carbohydrate restriction to 10E% (~70-90 grams)) on 24-hour average sensor glucose (primary outcome) in individuals with type 2 diabetes compared with a 16 day control period with a conventional diet. 24-hour average sensor glucose is measured by patient-blinded continuous glucose monitoring (CGM) during the intervention and control period.

The 2 groups in the trial

  • Intermittent carbohydrate restrictionTreatment being tested

    16 days of intermittent carbohydrate restriction: a controlled dietary regime alternating between two days of restricting carbohydrate intake to 70-90 grams, and two days of a conventional control diet. Protein content is matched between diets. All food is provided.

    Treatment: Dietary macronutrient composition

  • Control armNo study treatment, for comparison

    During the control period (16 days) the macronutrient composition matches that of the non-carbohydrate-restricted days of the intermittent carbohydrate intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06144593, who can take part
Record updated
16 November 2026